NYMC Faculty Publications
Congenital Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon Successfully Treated With Low-Dose Radiation Therapy
Author Type(s)
Faculty
DOI
10.1111/pde.12090
Journal Title
Pediatric Dermatology
First Page
595
Last Page
598
Document Type
Article
Publication Date
1-1-2014
Department
Dermatology
Second Department
Pediatrics
Keywords
Diagnosis, Differential, Diagnostic Imaging, Hemangioendothelioma, Humans, Infant, Newborn, Kasabach-Merritt Syndrome, Male, Prenatal Diagnosis, Radiotherapy Dosage, Sarcoma, Kaposi
Disciplines
Medicine and Health Sciences
Abstract
Kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon is a life-threatening vasculopathy. The current mainstay treatment for KHEs is corticosteroids and chemotherapy, but these medications do not work for all patients and carry significant side effects. We report a neonate with a large congenital KHE who responded extremely well to low-dose radiation therapy.
Recommended Citation
Malhotra, Y., Yang, C. S., McNamara, J., & Antaya, R. J. (2014). Congenital Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon Successfully Treated With Low-Dose Radiation Therapy. Pediatric Dermatology, 31 (5), 595-598. https://doi.org/10.1111/pde.12090
